NETCLASS TECHNOLOGY INC Completes $2.4 Million Private Placement (PIPE) Financing

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Nov 14 2025

0mins

NTCL-5.41%

Should l Buy NTCL?

Source: Newsfilter

PIPE Financing Announcement: NETCLASS Technology INC successfully closed a PIPE financing round, raising approximately $2.4 million by issuing 1,500,000 Class A ordinary shares at $1.60 each, led by an institutional investor.
Strategic Use of Proceeds: The funds will be used to expand AI applications, advance blockchain technology, and promote the EDC token in Singapore, aligning with the company's goal to enhance its global reach in education technology.
Company Vision: Dr. Jianbiao Dai, CEO of NetClass, emphasized that this financing milestone supports their vision to transform education through technology and accelerate the rollout of their AI-driven education ecosystem.
Company Overview: NETCLASS Technology INC specializes in B2B smart education IT solutions, offering services such as SaaS, application software development, and blockchain systems, with a mission to deliver high-quality products for sustainable growth.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy NTCL?" and start using high-conviction signals backed by rigorous historical data.

NTCL

$0.367+Infinity%1D

Analyst Views on NTCL

About NTCL

NetClass Technology Inc is a holding company principally engaged in the provision of online education platform and related courseware, and education Information Technology (IT) solutions. The Company's main products and services include Smart Campus Solutions, NetClass Mobile Learning Platforms, Education Credit (EDC) Blockchain System, NetClass Online Examination System, NetClass Epidemic Prevention and Control System, Online Lecturer Evaluation Services, as well as Application Development Services. The Company provides services for schools, training institutions, corporations, public agencies, and other institutions or corporate customers.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

NetClass Technology Receives Nasdaq Compliance Notification

Jan 29 2026seekingalpha

Compliance Notification: NetClass Technology has received a notification from Nasdaq indicating that its Class A ordinary shares have failed to meet the minimum bid price requirement of $1 for 30 consecutive business days.
Trading Impact: Despite the notification, the company's shares will continue to trade under the symbol NTCL, with the current price at $0.435, reflecting a 3.52% increase in after-hours trading, indicating market optimism regarding future compliance.
Compliance Deadline: The company has been granted 180 calendar days until July 27, 2026, to regain compliance, highlighting the timeframe available for the company to implement necessary measures to meet Nasdaq's requirements.
Remedial Options Assessment: NetClass is evaluating potential remedial options, including a reverse stock split if necessary, although there is no assurance of regaining compliance, underscoring the challenges and uncertainties the company faces.

NetClass Technology Faces Nasdaq Delisting Risk

Jan 29 2026Newsfilter

Nasdaq Notification: On January 27, 2026, NetClass Technology received a notification from Nasdaq indicating that it no longer meets the minimum bid price requirement of $1 per share based on the last 30 business days, although trading continues uninterrupted.
Compliance Period: The company has been granted a 180-day compliance period until July 27, 2026, to regain compliance with Nasdaq listing requirements, and may need to consider a reverse stock split if it fails to meet the criteria.
Compliance Evaluation: The company is currently evaluating options to regain compliance and is committed to meeting Rule 5550(a)(2), but there is no assurance of success, highlighting the financial pressures it faces.
Business Context: As a leading B2B smart education IT solutions provider serving schools and public agencies, the compliance issue may impact the company's market credibility and future financing capabilities.

Rapt Therapeutics Acquired by GSK for $58 per Share, Valuing at $2.2 Billion

Jan 20 2026Benzinga

Acquisition Deal: GSK has agreed to acquire Rapt Therapeutics for $58 per share, representing an estimated total equity value of $2.2 billion, which will significantly enhance GSK's market position in the biopharmaceutical sector.
Stock Surge: Rapt Therapeutics' shares jumped 63.4% to $57.36 in pre-market trading, reflecting a positive market reaction to the acquisition, which may attract more investor interest in the company.
Market Impact: This acquisition not only increases shareholder value for Rapt but may also prompt other biotech firms to consider similar strategic acquisitions to enhance their competitiveness and market share.
Industry Outlook: With GSK's acquisition, Rapt's product development process is expected to accelerate, potentially leading to faster drug launches and further solidifying GSK's leadership position in the innovative pharmaceuticals market.